Wedge Industrial Co.,Ltd.

000534

CNE0000004T4

Pharmaceuticals

End-of-day quote Shenzhen S.E. Other stock markets 06:00:00 2024-05-29 pm EDT			5-day change	1st Jan Change
11.11 ^CNY	-0.18%		-2.29%	-15.13%

Apr. 28	Wedge Industrial Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Apr. 02	Tranche Update on Wedge Industrial Co.,Ltd.'s Equity Buyback Plan announced on August 28, 2023.	CI

Wedge Industrial Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023

April 27, 2023 at 08:03 am EDT

Wedge Industrial Co.,Ltd. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was CNY 281.48 million compared to CNY 136.37 million a year ago. Revenue was CNY 281.48 million compared to CNY 136.37 million a year ago.

Net income was CNY 58.51 million compared to CNY 32.66 million a year ago. Basic earnings per share from continuing operations was CNY 0.1169 compared to CNY 0.0654 a year ago. Diluted earnings per share from continuing operations was CNY 0.1156 compared to CNY 0.0644 a year ago.

Latest news about Wedge Industrial Co.,Ltd.

Wedge Industrial Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 28	CI
Tranche Update on Wedge Industrial Co.,Ltd.'s Equity Buyback Plan announced on August 28, 2023.	Apr. 02	CI
Wedge Industrial Co.,Ltd. Proposes Final Cash Dividend for 2023	Apr. 01	CI
Wedge Industrial Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 29	CI
Tranche Update on Wedge Industrial Co.,Ltd.'s Equity Buyback Plan announced on August 28, 2023.	Jan. 03	CI
Wedge Industrial Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-17	CI
Sichuan Yanyang Biotechnology Co., Ltd. announced that it has received funding from Wedge Industrial Co.,Ltd.	23-09-25	CI
Wedge Industrial Co.,Ltd.(XSEC:000534) added to S&P Global BMI Index	23-09-18	CI
Wedge Industrial's Unit Signs 102.1 Million Yuan Worth of Contracts	23-09-06	MT
Wedge Industrial Co.,Ltd. announces an Equity Buyback for CNY 500 million worth of its shares.	23-08-28	CI
Wedge Industrial Co.,Ltd. authorizes a Buyback Plan.	23-08-27	CI
Wedge Industrial Co.,Ltd. Announces Final Dividend on A Shares for the Year 2022, Payable on 29 August 2023	23-08-22	CI
Wedge Industrial Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-18	CI
Wedge Industrial Co.,Ltd. Approves Profit Distribution for 2022	23-07-03	CI
Wedge Industrial Co.,Ltd. entered into an agreement to acquire Shenzhen Suborui Aviation Materials Co., Ltd. from Shenzhen Suborui New Material Co., Ltd. for CNY 30 million.	23-06-09	CI
Wedge Industrial Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-27	CI
Wedge Industrial Earmarks 697 Million Yuan to Boost Superalloy Capacity	23-03-15	MT
Wedge Industrial’s Profit Rises 7.7% in 2022 as Revenue Jumps 21%	23-02-17	MT
Wedge Industrial Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-02-16	CI
Shenzhen Wanze Hongye Industrial Development Co., Ltd. cancelled the acquisition of 10% stake in Xi'an Xinhongye Investment Development Co., Ltd.	22-12-30	CI
Wedge Industrial Unit Applies For $49 Million Bank Loan	22-11-25	MT
Wedge Industrial Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-14	CI
Wedge Industrial Co.,Ltd. announced that it expects to receive CNY 1.2 billion in funding	22-09-27	CI
Wedge Industrial Co.,Ltd. Announces Final Dividend on A Shares for the Year 2021, Payable on 29 August 2022	22-08-22	CI
Shenzhen Shenshan Special Cooperation Zone Wanze Precision Technology Co., Ltd announced that it expects to receive CNY 100 million in funding from Wedge Industrial Co.,Ltd.	22-08-16	CI

Chart Wedge Industrial Co.,Ltd.

Duration

Period

More charts

Company Profile

Wedge Industrial Co Ltd is a China-based company mainly engaged in pharmaceutical manufacturing business. The Company's main businesses include the research and development, production and sales of micro-ecological live bacteria products, superalloys and products thereof. The Company also engages in metal detection and processing services. The Company's products include bifidobacterium lactobacillus triple viable bacteria tablets, vaginal lactobacillus viable bacteria capsules and probiotic dietary supplements and other micro-ecological viable bacteria products, as well as precision casting blades, superalloy powder discs, high temperature master alloys and alloy powder and other high-temperature alloy products. The Company mainly operates its businesses in the domestic and overseas markets.

Sector

Pharmaceuticals

Calendar

2024-09-01 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

11.11

Average target price

Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

	1st Jan change	Capi.
WEDGE INDUSTRIAL CO.,LTD.	-15.13%	733M
ELI LILLY AND COMPANY	+39.88%	734B
NOVO NORDISK A/S	+32.83%	591B
JOHNSON & JOHNSON	-6.41%	350B
MERCK & CO., INC.	+15.90%	315B
ABBVIE INC.	+1.55%	276B
ASTRAZENECA PLC	+15.04%	238B
NOVARTIS AG	+9.53%	206B
ROCHE HOLDING AG	-5.19%	204B
AMGEN INC.	+5.60%	161B

Other Pharmaceuticals